Chemotherapy-Free Triplet ‘Sets a New Benchmark’ in Follicular Lymphoma
(MedPage Today) -- ORLANDO -- Adding the bispecific antibody epcoritamab (Epkinly) to a standard chemotherapy-free regimen for relapsed or refractory ...
‘This Would Be a Hugely Important Finding’: What We Heard This Week
(MedPage Today) -- "If the shingles vaccine really prevents or delays dementia ... this would be a hugely important finding ...
Alzheimer’s Benefits May Continue After Donanemab Treatment Ends, Data Suggest
(MedPage Today) -- New data suggested that donanemab (Kisunla) sustained long-term benefits after a limited dosing period in a subgroup ...
Hematocrit, Phlebotomy Benefits Seen With Rusfertide in PV
No new safety concerns emerged in the 20-week extension of the phase 3 VERIFY study. Medscape Medical News Source link ...
Potential Game-Changing Impact on Mismatched Unrelated Blood Cell Transplantation
(MedPage Today) -- ORLANDO -- Stem-cell transplants with mismatched unrelated donors (MMUDs) beyond a single HLA locus (
TBI-Free Conditioning Before Transplant Effective in MRD-Negative B-ALL
(MedPage Today) -- ORLANDO -- A conditioning regimen free from total body irradiation (TBI) appeared to be just as effective ...
AML: Clinical Data Confirms Lower Survival in Black Patients
Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...
The Internet’s Risky Pseudo-Cures
(MedPage Today) -- In my last emergency medicine rotation, I (Bhaskar) met a patient with a rash. Jane*, whom I ...
Want Good Info on Epilepsy Treatment? Don’t Ask Dr. TikTok
(MedPage Today) -- ATLANTA -- Much of the content on social media regarding epilepsy treatment isn't accurate and could actually ...
Fixed-Duration or Continuous Therapy in CLL: Trial Says Take Your Pick
(MedPage Today) -- ORLANDO -- A year of combination therapy for previously untreated chronic lymphocytic leukemia (CLL) patients led to ...
